• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用半胱氨酸反应性串联质量标签测量心肌中的 S-亚硝基化占有率:简短交流。

Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication.

机构信息

Laboratory of Cardiac Physiology, Systems Biology Center, National Heart Lung and Blood Institute, Bethesda, MD 20892, USA.

出版信息

Circ Res. 2012 Oct 26;111(10):1308-12. doi: 10.1161/CIRCRESAHA.112.271320. Epub 2012 Aug 3.

DOI:10.1161/CIRCRESAHA.112.271320
PMID:22865876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3483371/
Abstract

RATIONALE

S-nitrosylation (SNO) is a reversible, thiol-based protein modification that plays an important role in the myocardium by protecting critical cysteine residues from oxidation. However, little is known with regard to the percentage of a given protein that is modified by SNO (ie, SNO occupancy). Current methods allow for the relative quantification of SNO levels, but not for the determination of SNO occupancy.

OBJECTIVE

To develop a method for the measurement of SNO occupancy, and apply this methodology to determine SNO occupancy in the myocardium.

METHODS AND RESULTS

We developed a differential cysteinereactive tandem mass tag (cysTMT) labeling procedure for the measurement of SNO occupancy. To validate this cysTMT labeling method, we treated whole-heart homogenates with the S-nitrosylating agent S-nitrosoglutathione and determined maximal SNO occupancy. We also examined SNO occupancy under more physiological conditions and observed that SNO occupancy is low for most protein targets at baseline. Following ischemic preconditioning, SNO occupancy increased to an intermediate level compared to baseline and Snitrosoglutathione treatment, and this is consistent with the ability of SNO to protect against cysteine oxidation.

CONCLUSIONS

This novel cysTMT labeling approach provides a method for examining SNO occupancy in the myocardium. Using this approach, we demonstrated that IPC-induced SNO occupancy levels are sufficient to protect against oxidation.

摘要

原理

S-亚硝基化(SNO)是一种可逆的、基于巯基的蛋白质修饰,通过保护关键半胱氨酸残基免受氧化,在心肌中发挥重要作用。然而,对于特定蛋白质被 SNO 修饰的百分比(即 SNO 占有率)知之甚少。目前的方法允许相对定量 SNO 水平,但不能确定 SNO 占有率。

目的

开发一种测量 SNO 占有率的方法,并应用该方法测定心肌中的 SNO 占有率。

方法和结果

我们开发了一种用于测量 SNO 占有率的差异半胱氨酸反应性串联质量标签(cysTMT)标记程序。为了验证这种 cysTMT 标记方法,我们用 S-亚硝酰谷胱甘肽处理全心脏匀浆,并确定最大 SNO 占有率。我们还在更生理的条件下检查了 SNO 占有率,观察到大多数蛋白质靶标在基线时 SNO 占有率较低。与基线和 S-nitrosoglutathione 处理相比,缺血预处理后 SNO 占有率增加到中间水平,这与 SNO 保护半胱氨酸氧化的能力一致。

结论

这种新的 cysTMT 标记方法为研究心肌中的 SNO 占有率提供了一种方法。使用这种方法,我们证明 IPC 诱导的 SNO 占有率足以防止氧化。

相似文献

1
Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication.用半胱氨酸反应性串联质量标签测量心肌中的 S-亚硝基化占有率:简短交流。
Circ Res. 2012 Oct 26;111(10):1308-12. doi: 10.1161/CIRCRESAHA.112.271320. Epub 2012 Aug 3.
2
Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture.用树脂辅助捕获技术在预处理和缺血/再灌注损伤期间同时测量蛋白质氧化和 S-亚硝基化。
Circ Res. 2011 Feb 18;108(4):418-26. doi: 10.1161/CIRCRESAHA.110.232173. Epub 2010 Dec 30.
3
A twist on quantification: measuring the site occupancy of S-nitrosylation.定量分析的一种新方法:测量S-亚硝基化的位点占有率。
Circ Res. 2012 Oct 26;111(10):1253-5. doi: 10.1161/CIRCRESAHA.112.278721.
4
Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection.用于减少不同半胱氨酸亚群衍生偏差的双标记生物素开关检测法:一种最大化S-亚硝基化检测的方法。
Circ Res. 2015 Oct 23;117(10):846-57. doi: 10.1161/CIRCRESAHA.115.307336. Epub 2015 Sep 3.
5
Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay.通过半胱氨酸反应性串联质量标签开关测定法鉴定和定量 S-亚硝基化。
Mol Cell Proteomics. 2012 Feb;11(2):M111.013441. doi: 10.1074/mcp.M111.013441. Epub 2011 Nov 29.
6
Quantification of mitochondrial S-nitrosylation by CysTMT⁶ switch assay.通过CysTMT⁶转换分析法对线粒体S-亚硝基化进行定量分析。
Methods Mol Biol. 2013;1005:169-79. doi: 10.1007/978-1-62703-386-2_14.
7
Characterization of potential S-nitrosylation sites in the myocardium.心肌中潜在 S-亚硝基化位点的表征。
Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1327-35. doi: 10.1152/ajpheart.00997.2010. Epub 2011 Jan 28.
8
S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death.TRIM72在半胱氨酸144处的S-亚硝基化对于防止氧化诱导的蛋白质降解和细胞死亡至关重要。
J Mol Cell Cardiol. 2014 Apr;69:67-74. doi: 10.1016/j.yjmcc.2014.01.010. Epub 2014 Jan 30.
9
Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry.使用半胱氨酸肽富集结合质谱法对小鼠骨骼肌中的 S-亚硝基化进行定量的位点特异性反应性分析。
Free Radic Biol Med. 2013 Apr;57:68-78. doi: 10.1016/j.freeradbiomed.2012.12.010. Epub 2012 Dec 28.
10
SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures.SNOSID,一种用于鉴定复杂蛋白质混合物中半胱氨酸S-亚硝基化位点的蛋白质组学方法。
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1012-7. doi: 10.1073/pnas.0508412103. Epub 2006 Jan 17.

引用本文的文献

1
The Role of Protein S-Nitrosylation in Mitochondrial Quality Control in Central Nervous System Diseases.蛋白质S-亚硝基化在中枢神经系统疾病线粒体质量控制中的作用
Aging Dis. 2024 Mar 25;16(5):2641-2658. doi: 10.14336/AD.2024.0099.
2
Oxidative Post-translational Protein Modifications upon Ischemia/Reperfusion Injury.缺血/再灌注损伤后的蛋白质氧化翻译后修饰
Antioxidants (Basel). 2024 Jan 16;13(1):106. doi: 10.3390/antiox13010106.
3
Chemoproteomic strategy identified p120-catenin glutathionylation regulates E-cadherin degradation and cell migration.

本文引用的文献

1
Profiling thiol redox proteome using isotope tagging mass spectrometry.使用同位素标记质谱法分析硫醇氧化还原蛋白质组。
J Vis Exp. 2012 Mar 24(61):3766. doi: 10.3791/3766.
2
Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay.通过半胱氨酸反应性串联质量标签开关测定法鉴定和定量 S-亚硝基化。
Mol Cell Proteomics. 2012 Feb;11(2):M111.013441. doi: 10.1074/mcp.M111.013441. Epub 2011 Nov 29.
3
Methodologies for the characterization, identification and quantification of S-nitrosylated proteins.
化学生物学策略鉴定出 p120 连环蛋白的谷胱甘肽化调节 E-钙黏蛋白降解和细胞迁移。
Cell Chem Biol. 2023 Dec 21;30(12):1542-1556.e9. doi: 10.1016/j.chembiol.2023.08.004. Epub 2023 Sep 14.
4
Hsp70 in Redox Homeostasis.热休克蛋白 70 在氧化还原平衡中的作用。
Cells. 2022 Feb 28;11(5):829. doi: 10.3390/cells11050829.
5
Organic mercury solid phase chemoselective capture for proteomic identification of S-nitrosated proteins and peptides.用于蛋白质组学鉴定 S-亚硝化蛋白质和肽的有机汞固相化学选择性捕获。
Nitric Oxide. 2021 Dec 1;117:1-6. doi: 10.1016/j.niox.2021.09.004. Epub 2021 Sep 15.
6
Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration.蛋白质 S-亚硝基化和氧化导致神经退行性变中的蛋白质错误折叠。
Free Radic Biol Med. 2021 Aug 20;172:562-577. doi: 10.1016/j.freeradbiomed.2021.07.002. Epub 2021 Jul 2.
7
Implications of Oxidative and Nitrosative Post-Translational Modifications in Therapeutic Strategies against Reperfusion Damage.氧化和亚硝化翻译后修饰在抗再灌注损伤治疗策略中的意义
Antioxidants (Basel). 2021 May 8;10(5):749. doi: 10.3390/antiox10050749.
8
Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO.马凡综合征中的主动脉疾病是由 NO 引起的 sGC-PRKG 信号过度激活引起的。
Nat Commun. 2021 May 11;12(1):2628. doi: 10.1038/s41467-021-22933-3.
9
Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia-Reperfusion.S-亚硝基谷胱甘肽还原酶的药理学抑制作用可减轻缺血再灌注诱导的心脏损伤。
Antioxidants (Basel). 2021 Apr 2;10(4):555. doi: 10.3390/antiox10040555.
10
Post-Translational S-Nitrosylation of Proteins in Regulating Cardiac Oxidative Stress.蛋白质的翻译后S-亚硝基化在调节心脏氧化应激中的作用
Antioxidants (Basel). 2020 Oct 28;9(11):1051. doi: 10.3390/antiox9111051.
S-亚硝基化蛋白质的表征、鉴定和定量方法。
Biochim Biophys Acta. 2012 Jun;1820(6):675-83. doi: 10.1016/j.bbagen.2011.03.013. Epub 2011 Apr 5.
4
Characterization of potential S-nitrosylation sites in the myocardium.心肌中潜在 S-亚硝基化位点的表征。
Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1327-35. doi: 10.1152/ajpheart.00997.2010. Epub 2011 Jan 28.
5
Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture.用树脂辅助捕获技术在预处理和缺血/再灌注损伤期间同时测量蛋白质氧化和 S-亚硝基化。
Circ Res. 2011 Feb 18;108(4):418-26. doi: 10.1161/CIRCRESAHA.110.232173. Epub 2010 Dec 30.
6
Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection.心脏线粒体中体外 S-亚硝化的位点映射:对心脏保护的影响。
Mol Cell Proteomics. 2011 Mar;10(3):M110.004721. doi: 10.1074/mcp.M110.004721. Epub 2010 Oct 29.
7
Cysteine S-nitrosylation protects protein-tyrosine phosphatase 1B against oxidation-induced permanent inactivation.半胱氨酸S-亚硝基化可保护蛋白酪氨酸磷酸酶1B免受氧化诱导的永久性失活。
J Biol Chem. 2008 Dec 12;283(50):35265-72. doi: 10.1074/jbc.M805287200. Epub 2008 Oct 7.
8
Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport.预处理导致参与线粒体能量代谢和钙转运调节的蛋白质发生S-亚硝基化。
Circ Res. 2007 Nov 26;101(11):1155-63. doi: 10.1161/CIRCRESAHA.107.155879. Epub 2007 Oct 4.
9
Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics.通过比较蛋白质组学在线粒体蛋白质中鉴定出的缺血性心脏损伤潜在生物标志物。
Proteomics. 2006 Feb;6(4):1237-49. doi: 10.1002/pmic.200500291.
10
Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury.超收缩性雌性心脏表现出L型钙通道α1亚基的S-亚硝基化增加,且缺血/再灌注损伤减轻。
Circ Res. 2006 Feb 17;98(3):403-11. doi: 10.1161/01.RES.0000202707.79018.0a. Epub 2006 Jan 5.